ustekinumab

As nouns the difference between terms and ustekinumab

is that terms is while ustekinumab is a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

As nouns the difference between arthritis and ustekinumab

is that arthritis is arthritis while ustekinumab is a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

As an adjective psoriatic

is of or pertaining to psoriasis.

As a noun ustekinumab is

a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

As nouns the difference between psoriasis and ustekinumab

is that psoriasis is psoriasis while ustekinumab is a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

As nouns the difference between interleukin and ustekinumab

is that interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while ustekinumab is a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

As an adjective human

is (label) classical (of or pertaining to the classical - latin, greek - languages, literature, history and philosophy).

As a noun ustekinumab is

a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.